1. Home
  2. AXTI vs CRVO Comparison

AXTI vs CRVO Comparison

Compare AXTI & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • CRVO
  • Stock Information
  • Founded
  • AXTI 1986
  • CRVO 2001
  • Country
  • AXTI United States
  • CRVO United States
  • Employees
  • AXTI N/A
  • CRVO N/A
  • Industry
  • AXTI Semiconductors
  • CRVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXTI Technology
  • CRVO Health Care
  • Exchange
  • AXTI Nasdaq
  • CRVO Nasdaq
  • Market Cap
  • AXTI 93.9M
  • CRVO 98.3M
  • IPO Year
  • AXTI 1998
  • CRVO N/A
  • Fundamental
  • Price
  • AXTI $2.27
  • CRVO $2.22
  • Analyst Decision
  • AXTI Strong Buy
  • CRVO Buy
  • Analyst Count
  • AXTI 5
  • CRVO 8
  • Target Price
  • AXTI $5.30
  • CRVO $38.75
  • AVG Volume (30 Days)
  • AXTI 373.5K
  • CRVO 1.0M
  • Earning Date
  • AXTI 10-31-2024
  • CRVO 11-12-2024
  • Dividend Yield
  • AXTI N/A
  • CRVO N/A
  • EPS Growth
  • AXTI N/A
  • CRVO N/A
  • EPS
  • AXTI N/A
  • CRVO N/A
  • Revenue
  • AXTI $94,685,000.00
  • CRVO $10,066,550.00
  • Revenue This Year
  • AXTI $32.13
  • CRVO $34.17
  • Revenue Next Year
  • AXTI $12.84
  • CRVO N/A
  • P/E Ratio
  • AXTI N/A
  • CRVO N/A
  • Revenue Growth
  • AXTI 15.24
  • CRVO 116.29
  • 52 Week Low
  • AXTI $1.73
  • CRVO $1.80
  • 52 Week High
  • AXTI $5.64
  • CRVO $26.38
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 53.80
  • CRVO 26.40
  • Support Level
  • AXTI $2.16
  • CRVO $1.80
  • Resistance Level
  • AXTI $2.38
  • CRVO $2.36
  • Average True Range (ATR)
  • AXTI 0.13
  • CRVO 0.90
  • MACD
  • AXTI 0.01
  • CRVO -0.14
  • Stochastic Oscillator
  • AXTI 58.54
  • CRVO 3.33

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single-element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: